Results 121 to 130 of about 546,915 (262)

Effects of Intravenous Administration of Vancomycin on Peritonitis in a Patient on Peritoneal Dialysis

open access: yesClinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT In settings where intraperitoneal vancomycin is unavailable or off‐label (e.g., Japan), intravenous vancomycin can be a viable treatment option for peritoneal dialysis‐associated peritonitis. Due to limited pharmacokinetic data regarding intravenous dosing, pragmatic strategies involving more frequent therapeutic drug monitoring—measuring both
Natsuri Yonezawa   +11 more
wiley   +1 more source

Different cerebrospinal fluid drainage methods and chronic hydrocephalus in patients with aneurysmal subarachnoid hemorrhage

open access: yesFrontiers in Neurology
BackgroundChronic hydrocephalus represents a common complication following aneurysmal subarachnoid hemorrhage (aSAH); however, the underlying mechanisms driving its pathogenesis remain incompletely understood.
Yang Zhou   +8 more
doaj   +1 more source

Cilostazol May Prevent Cerebral Vasospasm Following Subarachnoid Hemorrhage

open access: gold, 2009
Tetsuyuki Yoshimoto   +7 more
openalex   +2 more sources

Selective Deletion of NBCe1 in Reactive Astrocytes Attenuates Ischemic Stroke Brain Damage

open access: yesGlia, Volume 73, Issue 12, Page 2386-2406, December 2025.
Main Points NBCe1 is upregulated in reactive astrocytes following ischemic stroke. Deletion of astrocytic Nboe1 reduces stroke volume, preserves AQP4 polarization, reduces BBB permeability, and improves neurological function after ischemic stroke. ABSTRACT The electrogenic sodium bicarbonate transporter 1 (NBCe1/Slc4a4), predominantly expressed in ...
Okan Capuk   +16 more
wiley   +1 more source

Epcoritamab for Relapsed/Refractory EBV+ Post‐Transplant Lymphoproliferative Disorder of DLBCL‐Type

open access: yeseJHaem, Volume 6, Issue 6, December 2025.
Abstract Background Patients with relapsed/refractory post‐transplant lymphoproliferative disorder (R/R PTLD) following solid‐organ transplants (SOT) or hematopoietic stem cell transplants (HSCT) after frontline chemoimmunotherapy have dismal outcomes.
Li Yuan Chan   +3 more
wiley   +1 more source

Tissue Kallikrein as a Mediator in Stroke Outcomes among Patients With Metabolic Syndrome: A Multicenter Study Integrating Big Data and Biomarkers

open access: yesMedComm, Volume 6, Issue 12, December 2025.
Metabolic syndrome is associated with adverse stroke outcomes. KLK1 acts as a mediating factor linking metabolic syndrome and stroke prognosis. KLK1 could be a therapeutic target for stroke patients with metabolic comorbidities. ABSTRACT Metabolic syndrome (MetS) poses a significant risk to the cerebrovascular system, impacting the prognosis of stroke ...
Hang Ruan   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy